Patents Assigned to Nanogen
  • Patent number: 7129229
    Abstract: This invention relates to attachment chemistries for binding macromolecules to a substrate surface or to other conjugation targets. More particularly, this invention relates to attachment chemistries involving branched or linear structures having one or more hydrazide attachment moieties for binding the macromolecules to a substrate surface, or for other conjugation reactions. Novel modifying reagents are provided for the introduction of protected hydrazide attachment moieties or precursor forms of such hydrazides to the macromolecule, either as a single hydrazide or as multiple hydrazides.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: October 31, 2006
    Assignee: Nanogen Recognomics GmbH
    Inventors: Stefan Raddatz, Jochen Müller-Ibeler, Markus Schweitzer, Christoph Brücher, Norbert Windhab, John R. Havens, Thomas J. Onofrey, Charles H. Greef, Daguang Wang
  • Patent number: 7125678
    Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
    Type: Grant
    Filed: November 23, 2001
    Date of Patent: October 24, 2006
    Assignee: Nanogen, Inc.
    Inventors: George Jackowski, John Marshall
  • Patent number: 7122327
    Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
    Type: Grant
    Filed: November 23, 2001
    Date of Patent: October 17, 2006
    Assignee: Nanogen Inc.
    Inventors: George Jackowski, John Marshall
  • Patent number: 7101717
    Abstract: An addressable biologic electrode array includes an array of electrodes disposed on a support, the array of electrodes being selectively addressed and driven using a memory associated with each electrode of the array, the driven electrodes being driven at one of a plurality of stimulus levels by a source of electrical current or voltage external to the array.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: September 5, 2006
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 7101661
    Abstract: A system for performing molecular biological diagnosis, analysis and multistep and multiplex reactions utilizes a selfaddressable, selfassembling microelectronic system for actively carrying out controlled reactions in microscopic formats. Preferably, a fluidic system flow a sample across an active area of the biochip, increasing diagnostic efficiency. Preferably, the fluidic system includes a flow cell having a window.
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: September 5, 2006
    Assignee: Nanogen, Inc.
    Inventors: Michael James Heller, Eugene Tu
  • Patent number: 7070961
    Abstract: A method of improving amplification of nucleic acids using a nucleic acid sequence-based amplification (“NASBA”) method is provided wherein target nucleic acids and NASBA primers are electronically addressed to electronically addressable capture sites of a microchip. This improvement uses electronically induced hybridization of the target nucleic acids to the primers. The primers may be solution-based or immobilized on the capture sites of the microchip.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: July 4, 2006
    Assignee: Nanogen/Becton Dickinson Partnership
    Inventors: Carl F. Edman, Michael I. Nerenberg
  • Publication number: 20060134657
    Abstract: A new, extremely sensitive, and rapid electronic detection method for direct detection of hybridized genomic targets to specific probes on the microarray is proposed. The method consists of fast electronic accumulation of the DNA target on a particular electrode site at the micro-electrode array, sequential electronic hybridization of oligonucleotide labeled metallic (nano)particles on the target DNA and monitoring the electrochemical AC impedance changes at the electrode site. The method is enhanced by electroplating over the DNA target which serves as the metallization template and over the particles which provide seeds for rapid electroplating. The AC impedance changes are monitored during the electroplating over the DNA target and between the array electrodes sites.
    Type: Application
    Filed: May 27, 2005
    Publication date: June 22, 2006
    Applicant: NANOGEN, INC.
    Inventors: Dalibor Hodko, Daniel Smolko, Stuart Duffy
  • Patent number: 7060224
    Abstract: Methods and apparatus are provided for the fabrication of microscale, including micron and sub-micron scale, including nanoscale, devices. Electronic transport of movable component devices is utilized through a fluidic medium to effect transport to a desired target location on a substrate or motherboard. Forces include electrophoretic force, electroosmotic force, electrostatic force and/or dielectrophoretic force. In the preferred embodiment, free field electroosmotic forces are utilized either alone, or in conjunction with, other forces. These forces may be used singly or in combination, as well as in conjunction with yet other forces, such as fluidic forces, mechanical forces or thermal convective forces. Transport may be effected through the use of driving electrodes so as to transport the component device to yet other connection electrodes. In certain embodiments, the component devices may be attached to the target device using a solder reflow step.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: June 13, 2006
    Assignee: Nanogen, Inc.
    Inventors: Carl F. Edman, Michael J. Heller, Rachel Formosa, Christian Gurtner
  • Patent number: 7045097
    Abstract: A biologic electrode array is formed on a semiconductor substrate. A matrix of electrode sites is disposed on the semiconductor substrate. A matrix of optical detectors is disposed beneath the electrode sites in the semiconductor substrate, wherein each electrode site is associated with a corresponding optical detector. The optical detectors are coupled to detection circuitry formed on the semiconductor substrate. The electrode sites may include slitted electrodes, punctuated electrodes, or optically transparent electrodes.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: May 16, 2006
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Publication number: 20060065531
    Abstract: Methods for the transport and hybridization of a nucleic acid on an electrode device by providing a low conductivity buffer with a reducing agent to the device. The low conductivity buffer may also contain a zwitterion. A current and voltage is applied to a location of the device to effect electrophoretic transportation of the nucleic acid towards the location. The nucleic acid is then hybridized to a nucleic probed located at the location. The reducing agent in the low conductivity buffer may also be acting as a chaotropic agent.
    Type: Application
    Filed: September 22, 2005
    Publication date: March 30, 2006
    Applicant: Nanogen, Inc
    Inventors: Daniel Smolko, Paul Swanson, Dalibor Hodko, David Canter, Robert Haigis, Tricia Patterson
  • Patent number: 6989086
    Abstract: The present invention comprises devices and methods for performing channel-less separation of cell particles by dielectrophoresis, DC high voltage-pulsed electronic lysis of separated cells, separation of desired components from crude mixtures such as cell lysates, and/or enzymatic reaction of such lysates, all of which can be conducted on a single bioelectronic chip. A preferred embodiment of the present invention comprises a cartridge (10) including a microfabricated silicon chip (12) on a printed circuit board (14) and a flow cell (16) mounted to the chip (12) to form a flow chamber. The cartridge (10) also includes output pins (22) for electronically connecting the cartridge (10) to an electronic controller. The chip (12) % includes a plurality of circular microelectrodes (24) which are preferably coated with a protective permeation layer. Specific cells from various cell mixtures were separated, lysed, and enzymatically digested on the chip.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: January 24, 2006
    Assignee: Nanogen, Inc.
    Inventors: Jing Cheng, Edward L. Sheldon, III, Lei Wu, James P. O'Connell
  • Patent number: 6960298
    Abstract: The present invention provides improved synthetic polymer hydrogel permeation layers for use on active electronic matrix devices for biological assays. The permeation layers have a defined porous character, with mesopores in a size range between about 100 nanometers and about 1000 nanometers, and may also have micropores in the micrometer size range. The mesoporous synthetic hydrogel permeation layers demonstrate improved signal intensity and linearity characteristics as compared to nanoporous synthetic hydrogel permeation layers on active electronic matrix devices. In addition, the present invention also provides synthetic polymer hydrogel permeation layers which contain copolymerized attachment sites for nucleic acid probes or other biomolecules.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: November 1, 2005
    Assignee: Nanogen, Inc.
    Inventors: Jainamma Krotz, Daniel Smolko, Howard R. Reese, Thomas J. Onofrey, Daguang Wang, Theodore M. Winger, John R. Havens
  • Patent number: 6942778
    Abstract: The field of the present invention relates generally to a microstructure apparatus which may be used in a high-throughput screening context to monitor the rate of reaction of an enzyme with its substrate in cases where the product of the reaction has an altered net charge. For example, the systems and methods disclosed herein may be used to detect the activity of phosphatase enzymes, proteases and kinases on charged peptide substrates. The microstructure devices of the present invention comprise a plurality of microstructures, wherein each microstructure comprises a capture matrix located between two electrodes.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 13, 2005
    Assignee: Nanogen, Inc.
    Inventors: Shila Jalali, Alan Harper, Matt Simpson, Paul Swanson, John Havens
  • Patent number: 6911310
    Abstract: The present invention contemplates monitoring the amplification of nucleic acid using chromophore-containing polynucleotides having at least two donor chromophores operatively linked to the polynucleotide by linker arms, such that the chromophores are positioned by linkage along the length of the polynucleotide at a donor-donor transfer distance, and at least one fluorescing acceptor chromophore operatively linked to the polynucleotide by a linker arm, such that the fluorescing acceptor chromophore is positioned by linkage at a donor-acceptor transfer distance from at least one of the donor chromophores, to form a photonic structure for collecting photonic energy and transferring the energy to an acceptor chromophore, and methods using the photonic structures.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: June 28, 2005
    Assignee: Nanogen, Inc.
    Inventor: Michael J. Heller
  • Publication number: 20050136442
    Abstract: A method is provided for integrating sample preparation and multiplex assay of high volume samples for the presence of nucleic acid and antigen targets. The method uses a three dimensional platform, such as a column, for capturing desired targets out of the large volume sample. The column has a multiplicity of sample processing and target capture zones. The method further provides a simple and efficient sample pre-processing and testing methodology, as well as a simple and environmentally friendly detection methodology.
    Type: Application
    Filed: September 17, 2004
    Publication date: June 23, 2005
    Applicant: Nanogen, Inc.
    Inventor: Mark Collins
  • Patent number: 6893822
    Abstract: The present invention relates to conjugates of synthetic binding units and nucleic acids. The present invention also relates to methods for sorting and immobilizing nucleic acids on support materials using such conjugates by specific molecular addressing of the nucleic acids mediated by the synthetic binding systems. Particularly, the present invention also relates to novel methods of utilizing conjugates of synthetic binding units and nucleic acids to in active electronic array systems to produce novel array constructs from the conjugates, and the use of such constructs in various nucleic acid assay formats. In addition, the present invention relates to various novel forms of such conjugates, improved methods of making solid phase synthesized conjugates, and improved methods of conjugating pre-synthesized synthetic binding units and nucleic acids.
    Type: Grant
    Filed: July 19, 2001
    Date of Patent: May 17, 2005
    Assignee: Nanogen Recognomics GmbH
    Inventors: Markus Schweitzer, Richard R. Anderson, Michael D. Fiechtner, Jochen Müller, Stefan Raddatz, Christoph Brücher, Norbert Windhab, Jill M. Orwick, Eberhard Schneider, Marc Pignot, Stefan Kienle
  • Patent number: 6887362
    Abstract: This invention relates to devices and methods for performing active, multi-step molecular and biological sample preparation and diagnostic analyses employing immunochemical techniques. It relates generally to bioparticle separation, bioparticle enrichment, and electric field-mediated immunochemical detection on active electronic matrix devices utilizing AC and DC electric fields. More specifically, the invention relates to devices and methods for sample preparation/manipulation, immunoimmobilization, and immunoassays, all of which can be conducted on one or more active electronic chip devices within a single system. These manipulations are useful in a variety of applications, including, for example, detection of pathogenic bacteria and biological warfare agents, point-of-care diagnostics, food or medical product quality control assays, and other biological assays.
    Type: Grant
    Filed: February 6, 2002
    Date of Patent: May 3, 2005
    Assignee: Nanogen, Inc.
    Inventors: Ying Huang, Karla Ewalt, Robert Haigis, Anita Forster, Michael K. Krihak
  • Patent number: 6867048
    Abstract: A method of addressing and driving an electrode array includes the step of addressing one or more electrodes within the array using a plurality of row and column lines. In one aspect of the method, a value corresponding to a voltage is stored in a local memory associated with each electrode. The addressed electrodes are then driven at the voltages corresponding to the stored values. In another aspect of the method, a driving element associated with each addressed electrode is selectively coupled with a voltage line so as to charge the electrode with the voltage on the voltage line. The device and methods may be used in the synthesis of biopolymers such as oligonucleotides and peptides.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: March 15, 2005
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 6864071
    Abstract: This invention relates to devices, methods, and compositions of matter for the multiplex amplification and analysis of nucleic acid sequences in a sample using ligation-dependent strand displacement amplification technologies in combination with bioelectronic microchip technology.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: March 8, 2005
    Assignee: Nanogen/Becton Dickinson Partnership
    Inventors: John J. Carrino, Louis O. Gerrue, Jonathan M. Diver
  • Publication number: 20050004356
    Abstract: The present invention relates to a linker nucleoside, its preparation and use for the covalent bonding of biomolecules to oligonucleotides, in particular p-RNA oligonucleotides.
    Type: Application
    Filed: March 2, 2004
    Publication date: January 6, 2005
    Applicant: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Norbert Windhab, Tilmann Brandstetter, Stefan Scherer